Skip to main content
. Author manuscript; available in PMC: 2013 Aug 21.
Published in final edited form as: Circulation. 2012 Jul 11;126(8):963–974. doi: 10.1161/CIRCULATIONAHA.112.094722

Figure 1.

Figure 1

Elevated levels of ET-1 are associated with hyperaldosteronism in PAH. (a,b) Levels of ET-1 (n=4–6) and (c,d) aldosterone (ALDO) (n=4–8) were measured in plasma and lung tissue homogenates of Sprague-Dawley rats 25 days following treatment with vehicle control (V) or monocrotaline (MCT) (50 mg/kg). Horizontal line represents the median for each condition.